PMID: 2112583Jun 1, 1990Paper

Interferon gamma, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice

The Journal of Experimental Medicine
H HeremansA Billiau

Abstract

The involvement of cytokines in the pathogenesis of a generalized, Shwartzman-like lethal inflammatory response to bacterial lipopolysaccharides (LPS) was studied by testing the ability of cytokines or neutralizing anticytokine antibodies to modify the course of the syndrome. The reaction was elicitable in non-SPF NMRI mice by two consecutive injections of S. marcescens LPS: a first injection in the footpad, followed after 24 h by an intravenous dose; the size and route of the preparatory LPS dose were found to be critical. Treatment with mAbs against IFN-gamma was found to completely prevent the reaction. Treatment with IFN-gamma on the other hand, rendered the mice more sensitive to elicitation of the reaction. In contrast, systemic administration of IFN-alpha/beta exerted a desensitizing effect. The role of endogenous cytokines in the pathogenesis of this generalized Shwartzman reaction was also documented by a study of the cytokine levels in the serum of the mice. In comparisons between mice given lethal and nonlethal induction schedules, a good correlation was found between mortality rates and height of IFN or TNF levels, but no correlation was seen with IL-6 levels. Also, in mice that were protected by anti-IFN-gamma anti...Continue Reading

References

Nov 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·C GalanosW Reutter
Jun 1, 1986·The Journal of General Virology·P H van der MeideH Schellekens
May 1, 1988·European Journal of Immunology·T GeigerP C Heinrich
Jul 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·G E GrauP Vassalli
Aug 30, 1989·Biochemical and Biophysical Research Communications·B EveraerdtW Fiers
Jun 9, 1988·The New England Journal of Medicine·H R MichieD W Wilmore
Dec 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J Van SnickR J Simpson
Jan 1, 1988·Immunology Today·A Cerami, B Beutler
Nov 15, 1986·International Journal of Cancer. Journal International Du Cancer·P G BrouckaertW Fiers
Jun 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·I C KettelhutA L Goldberg
Dec 1, 1987·European Journal of Immunology·A BilliauC Dillen
Aug 18, 1988·The New England Journal of Medicine·E GirardinP H Lambert
Mar 1, 1988·The Journal of Infectious Diseases·K J TraceyA Cerami
Jun 1, 1988·The Journal of Experimental Medicine·A Waage, T Espevik
Jan 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J L Rothstein, H Schreiber
Oct 24, 1986·Science·K J TraceyJ D Albert
Oct 3, 1974·The New England Journal of Medicine·S M Wolff, J V Bennett
Sep 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·B D WilliamsonL J Old
Feb 10, 1984·Journal of Immunological Methods·H BazinF Cormont
Dec 1, 1952·The Journal of Experimental Medicine·L THOMAS, R A GOOD

❮ Previous
Next ❯

Citations

Jan 1, 1994·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S E BucklinD C Morrison
Dec 7, 2011·Archivum Immunologiae Et Therapiae Experimentalis·Matthew Morris, Liwu Li
Jan 1, 1993·Molecular Aspects of Medicine·R Burrell
Sep 1, 1992·Immunopharmacology·J P de BoerC E Hack
Feb 15, 1992·Veterinary Immunology and Immunopathology·A D NashM R Brandon
Nov 14, 1991·Biochemical and Biophysical Research Communications·K VandenbroeckA Billiau
Nov 3, 2001·Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology·E NakahataC Shindoh
Jun 10, 1998·Cytokine & Growth Factor Reviews·C A Dinarello
Jun 26, 2001·European Journal of Clinical Investigation·J de MetzH P Sauerwein
Jun 26, 2003·European Journal of Biochemistry·Bernhard SchmidSimon K Jackson
Feb 13, 2008·Proceedings of the National Academy of Sciences of the United States of America·Carrie M RosenbergerAlan Aderem
Mar 20, 2009·Proceedings of the National Academy of Sciences of the United States of America·Bernardo S FranklinRicardo T Gazzinelli
Aug 27, 2009·Proceedings of the National Academy of Sciences of the United States of America·Chiara PortaAntonio Sica
May 1, 1994·The Journal of Experimental Medicine·B D CarB Ryffel
Feb 15, 2001·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·D G AffleckJ Shelby
Sep 27, 2003·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Christian Schinkel
Apr 1, 1995·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·A BeigneuxM A Parant
Apr 1, 1997·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·J LuhmL Rink
Feb 6, 1998·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·M AnitescuJ S Cowdery
Feb 26, 2011·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Nele BerghmansHubertine Heremans
Apr 18, 2007·Journal of Burn Care & Research : Official Publication of the American Burn Association·David F SchneiderDouglas E Faunce
Feb 28, 2008·The Journal of Trauma·Guillermo M AlbaicetaFrancisco Taboada
Dec 1, 1991·European Journal of Clinical Investigation·A Billiau, F Vandekerckhove
Jan 26, 1999·Annals of the New York Academy of Sciences·C A Dinarello
Sep 9, 2011·Clinical and Vaccine Immunology : CVI·Shawn S JacksonNorman L Letvin
Jan 18, 2002·Infection and Immunity·Boping LiuYunn-Hwen Gan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.